Journal of Thoracic Oncology

ournal of Thoracic Oncology (JTO), the official Journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of thoracic malignancies. JTO emphasizes a multidisciplinary approach, and includes original research (clinical trials and translational or basic research), reviews, and opinion pieces. The audience consists of epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonary specialists, radiologists, pathologists, and research scientists with a special interest in thoracic oncology.

Publisher
Lippincott Williams & Wilkins
Some content from Wikipedia, licensed under CC BY-SA

High frequency of EGFR mutations found in Asian population

Adenocarcinoma histology, female sex, never-smoking status, and Asian ethnicity have been considered the most important factors associated with EGFR mutations in non-small cell lung cancer and response to EGFR inhibitors. ...

Feb 15, 2014
popularity 5 / 5 (1) | comments 0

Redefining the criteria for ALK positive lung cancer

A University of Colorado Cancer Center study published today in the journal Cancer shows that the current criteria used to match lung cancers with the drug crizotinib may miss some patients who could benefit from the drug. ...

Sep 10, 2013
popularity 4 / 5 (1) | comments 0

Need for national Canadian strategy for EGFR testing

Significant advances have taken place in the management of patients with advanced and metastatic non–small-cell lung cancer (NSCLC) over the last 5 years. Traditionally, all advanced NSCLC patients were treated in a similar ...

Jul 25, 2013
popularity not rated yet | comments 0